| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Université Catholique de Louvain, de Duve Institute, Brussels, Belgium
2 Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
3 Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, ID, USA
Correspondence
Thomas Michiels
thomas.michiels{at}uclouvain.be
Theiler's murine encephalomyelitis virus (TMEV or Theiler's virus) is a neurotropic picornavirus that can persist lifelong in the central nervous system of infected mice, causing a chronic inflammatory demyelinating disease. The leader (L) protein of the virus is an important determinant of viral persistence and has been shown to inhibit transcription of type I interferon (IFN) genes and to cause nucleocytoplasmic redistribution of host proteins. In this study, it was shown that expression of the L protein shuts off synthesis of the reporter proteins green fluorescent protein and firefly luciferase, suggesting that it induces a global shut-off of host protein expression. The L protein did not inhibit transcription or translation of the reporter genes, but blocked cellular mRNA export from the nucleus. This activity correlated with the phosphorylation of nucleoporin 98 (Nup98), an essential component of the nuclear pore complex. In contrast, the data confirmed that the L protein inhibited IFN expression at the transcriptional level, and showed that transcription of other chemokine or cytokine genes was affected by the L protein. This transcriptional inhibition correlated with inhibition of interferon regulatory factor 3 (IRF-3) dimerization. Whether inhibition of IRF-3 dimerization and dysfunction of the nuclear pore complex are related phenomena remains an open question. In vivo, IFN antagonism appears to be an important role of the L protein early in infection, as a virus bearing a mutation in the zinc finger of the L protein replicated as efficiently as the wild-type virus in type I IFN receptor-deficient mice, but had impaired fitness in IFN-competent mice.
A table showing the primers used in this study is available with the online version of this paper.
This article has been cited by other articles:
|
|
 |
|
  C. Ricour, F. Borghese, F. Sorgeloos, S. V. Hato, F. J. M. van Kuppeveld, and T. Michiels Random Mutagenesis Defines a Domain of Theiler's Virus Leader Protein That Is Essential for Antagonism of Nucleocytoplasmic Trafficking and Cytokine Gene Expression J. Virol., November 1, 2009; 83(21): 11223 - 11232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-N. Son, S. Pugazhenthi, and H. L. Lipton Activation of Tumor Suppressor Protein p53 Is Required for Theiler's Murine Encephalomyelitis Virus-Induced Apoptosis in M1-D Macrophages J. Virol., October 15, 2009; 83(20): 10770 - 10777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. Lidsky, L. I. Romanova, M. S. Kolesnikova, M. V. Bardina, E. V. Khitrina, S. V. Hato, F. J. M. van Kuppeveld, and V. I. Agol Interactions between Viral and Prokaryotic Pathogens in a Mixed Infection with Cardiovirus and Mycoplasma J. Virol., October 1, 2009; 83(19): 9940 - 9951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I. Romanova, P. V. Lidsky, M. S. Kolesnikova, K. V. Fominykh, A. P. Gmyl, E. V. Sheval, S. V. Hato, F. J. M. van Kuppeveld, and V. I. Agol Antiapoptotic Activity of the Cardiovirus Leader Protein, a Viral "Security" Protein J. Virol., July 15, 2009; 83(14): 7273 - 7284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fan, K.-N. Son, S. Y. Arslan, Z. Liang, and H. L. Lipton Theiler's Murine Encephalomyelitis Virus Leader Protein Is the Only Nonstructural Protein Tested That Induces Apoptosis When Transfected into Mammalian Cells J. Virol., July 1, 2009; 83(13): 6546 - 6553. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
